Stay updated with breaking news from Moore Simas. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The FDA approved zuranolone for postpartum depression in August, and the drug recently hit the market for patients this month. Experts are celebrating its delivery of care and rapid response rate.
Staff shortages and falling birth rates were cited by UMass Health as the driving forces behind the move.
Perinatal mental health conditions are the leading cause of maternal mortality or pregnancy-related death in the United States. UMass Chan researchers Nancy Byatt, DO, MS, MBA, and Tiffany Moore Simas, MD, MPH, MEd, have spearheaded creation of new resources to help obstetric care clinicians identify and care for patients with mental health conditions.
Pairing attorneys with an urban ob/gyn clinic is improving the lives of women and their babies, a new study has found.
The study followed more than 145,000 women and their children across the United States for up to 14 years.